Aminopeptidase activity in the postmortem brain of human heroin addicts

Neurochemistry International

Volumn 46, Issue 3, 2005, Pages 213-219

  Larrinaga, G ^a   Gil, J ^a   Meana, J J ^a   Ruiz, F ^a   Callado, L F ^a   Irazusta, J ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

Addiction; Aminopeptidase; Heroin; Opioid metabolism; Tolerance

Indexed keywords

2 NAPHTHYLAMINE; AMINOPEPTIDASE; AMINOPEPTIDASE B; ASPARTYL AMINOPEPTIDASE; DIAMORPHINE; ENKEPHALIN; MICROSOMAL AMINOPEPTIDASE; MORPHINE; PUROMYCIN; PUROMYCIN SENSITIVE AMINOPEPTIDASE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; AUTOPSY; BRAIN; BRAIN REGION; CAUDATE NUCLEUS; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; FLUOROMETRY; HEROIN DEPENDENCE; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MALE; NEUROBIOLOGY; PREFRONTAL CORTEX; PRIORITY JOURNAL;

ADULT; AMINOPEPTIDASES; ANTIGENS, CD13; BRAIN; CAUDATE NUCLEUS; ENDOPEPTIDASES; FEMALE; GLUTAMYL AMINOPEPTIDASE; HEROIN DEPENDENCE; HUMANS; MALE; POSTMORTEM CHANGES; PREFRONTAL CORTEX; SPECIMEN HANDLING;

EID: 12744259412     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2004.10.001     Document Type: Article

References (52)

1. F. Alba, C. Iribar, M. Ramírez, and C. Arenas A fluorimetric method for the determination of brain aminopeptidases Arch. Neurobiol. 52 1989 169 173
2. A. Balogh, S. Cadel, T. Foulon, R. Picart, A. Der Garabedian, A. Rousselet, C. Tougard, and P. Cohen Aminopeptidase B: a processing enzyme secreted and associated with the plasma membrane of rat pheochromocytoma (PC12) cells J. Cell. Sci. 111 1998 161 169
3. K.C. Berridge, and T.E. Robinson What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience Brain Res. Rev. 28 1998 309 369
4. M.M. Bradford A rapid and sensitive method for the quantification of microgram of protein utilizing the principle of protein-dye binding Anal. Biochem. 72 1976 248 254
5. S.L.T. Cappendijk, Y.L. Hurd, I. Nylander, J.M. van Ree, and L. Terenius A heroin-, but not cocaine-expecting, self administration state preferentially alters endogenous brain peptides Eur. J. Pharmacol. 365 1999 175 182
6. P. Chaillet, H. Marçais-Collado, J. Costentin, Y. Ching-Cheng, S. de la Baume, and J.C. Schwartz Inhibition of enkephalin metabolism by, and antinociceptive activity of bestatin, an aminopeptidase inhibitor Eur. J. Pharmacol. 86 1983 329 336
7. H.S. Cheung, and D.W. Cushman A soluble aspartate aminopeptidase from dog kidney Biochim. Biophys. Acta 242 1971 190 193
8. V. Clement-Jones, L. McLoughlin, P.J. Lowry, G.M. Besser, L.H. Rees, and H.L. Wen Accupunture in heroin addicts; changes in met-enkephalin and beta-endorphin in blood and cerebrospinal fluid Lancet 2 1979 380 383
9. D.B. Constam, A.R. Tobler, A. Rensing-Ehl, I. Kemler, L.B. Hersh, and A. Fontana Puromycin-sensitive aminopeptidase. Sequence analysis, expression, and functional characterization J. Biol. Chem. 270 1995 26931 26939
10. P.J. Crack, T.J. Wu, P.M. Cummins, E.S. Ferro, J.W. Tullai, M.J. Glucksman, and J.L. Roberts The association of metalloendopeptidase EC 3.4.24.15 at the extracellular surface of the AtT-20 cell plasma membrane Brain Res. 835 1999 113 124
11. S. De la Baume, C.C. Yi, J.C. Schwartz, P. Chaillet, C.H. Marcais, and J. Costentin Participation of both "enkephalinase" and aminopeptidase activities in the metabolism of endogenous enkephalins Neuroscience 8 1983 143 151
12. S.H. Dyer, C.A. Saughter, K. Orth, C.R. Moomaw, and L.B. Hersh Comparison of the soluble and membrane-bound forms of the puromycin sensitive enkephalin-degrading aminopeptidases from rat J. Neurochem. 54 1990 547 554
13. T. Foulon, S. Cadel, and P. Cohen Aminopeptidase B (EC 3. 4. 11. 6) Int. J. Biochem. Cell. Biol. 31 1998 747 750
14. W. Fratta, H.Y. Yang, J. Hong, and E. Costa Stability of Met-enkephalin content in brain structures of morphine-dependent or foot shock-stressed rats Nature 268 1977 452 453
15. 2-adrenoceptor agonist binding sites in the postmortem brain of heroin addicts Psychopharmacology 115 1994 135 140
16. A.M. Gibson, J.R. McDermott, B. Lauffart, and D. Manttle Specificity of action of human brain alanyl aminopeptidase on Leu-enkephalin and dynorphin-related peptides Neuropeptides 13 1989 259 262
17. J. Gil, G. Larrinaga, J.J. Meana, R. Rodriguez-Puertas, J. Irazusta, and L. Casis Regional and subcellular distribution of soluble aminopeptidases in the human and the rat brain: a comparative study Neuropeptides 35 2001 276 284
18. B. Giros, C. Gros, B. Solhone, and J.C. Schwartz Characterization of aminopeptidases responsible for inactivating endogenous (Met5)enkephalin in brain slices using peptidase inhibitors and antiaminopeptidase M antibodies Mol. Pharmacol 29 1986 281 287
19. J. Haffmans, M.V. Walsum, J.C. van Amsterdam, and M.R. Dzoljic Phelorphan, an inhibitor of enzymes involved in the biodegradation of enkephalins, affected the withdrawal symptoms in chronic morphine-dependent rats Neuroscience 22 1987 233 266
20. L.M. Harrison, A.J. Kastin, and J.A. Zadina Opiate tolerance and dependence: Receptors, G-Proteins and Antiopiates Peptides 19 1998 1603 1630
21. J. Irazusta, G. Larrinaga, N. Agirregoitia, A. Varona, and L. Casis Effects of morphine administration and its withdrawal on rat brain aminopeptidase activities Reg. Pept. 110 2003 225 230
22. J.A. Kelly, E.L. Neidle, and A. Neidle An aminopeptidase from mouse brain cytosol that cleaves N-terminal acidic aminoacid residues J. Neurochem. 40 1983 1727 1734
23. R. Maldonado, M.C. Fournié-Zaluski, and B.P. Roques Attenuation of the morphine withdrawal syndrome by inhibition of catabolism of endogenous enkephalins in the periacueductal gray matter Naunyn Schmiedeberg's Arch. Pharmacol. 345 1992 466 472
24. B. Malfroy, J.P. Swertz, A. Guyon, B.P. Roques, and J.C. Schwartz High-affinity enkephalin degrading peptidase in brain is increased after morphine Nature 276 1978 523 526
25. D. Mantle Comparison of soluble aminopeptidases in human cerebral cortex, skeletal muscle and kidney tissues Clin. Chim. Acta 207 1992 107 118
26. M.D. Mayas, M.J. Ramírez-Expósito, M.J. García, M. Ramírez, and J.M. Martínez-Martos Ethanol modifies differently aspartyl- and glutamyl-aminopeptidase activities in mouse frontal cortex synaptosomes Brain. Res. Bull. 57 2002 195 203
27. J.R. McDermott, D. Mantle, B. Lauffart, and A.M. Kidd Purification and characterization of a neuropeptide-degrading aminopeptidase from human brain J. Neurochem. 45 1985 752 759
28. J.J. Meana, J. Gonzalez-Maeso, J.A. Garcia-Sevilla, and J. Guimon Mu-opioid receptor and alpha2-adrenoceptor agonist stimulation of [35S]GTPgammaS binding to G-proteins in postmortem brains of opioid addicts Mol. Psychiatry 5 2000 308 315
29. M.F. Melzig, G. Heder, W.E. Siems, and J. Zipper Stimulation of endothelial angiotensin-converting enzyme by morphine via non-opioid receptor mediated processes Pharmazie 53 1998 634 637
30. I. Mocchetti, A. Ritter, and E. Costa Down-regulation of proopiomelanocortin synthesis and beta-endorphin utilization in hypothalamus of morphine-tolerant rats J. Mol. Neurosci. 1 1989 33 38
31. E.J. Nestler Molecular basis of long-term plasticity underlying addiction Nat. Rev. Neurosci. 2 2001 119 128
32. E.J. Nestler, and G.K. Aghajanian Molecular and cellular basis of addiction Science 278 1997 58 63
33. S.H. Paik, G.C. Camarao, J.A. Bauer, P.A. Leite, E.S. Oliveira, A.C. Camargo, and R.C. Farges Effects of morphine withdrawal syndrome on endo-oligopeptidase (EC 3. 4. 22. 19) activity Eur. J. Pharmacol 253 1994 101 106
34. P.V. Piazza, and M. Le Moal Pathophysiological basis of vulnerability to drug abuse: role of an interaction between stress, glucocorticoids, and dopaminergic neurons Annu. Rev. Pharmacol. Toxicol. 36 1996 359 378
35. R. Przewlocki, V. Höllt, T. Duka, G. Kleber, C. Gramsch, I. Haarmann, and A. Herz Long-term morphine treatment decreases endorphin levels in rat brain and pituitary Brain Res. 174 1979 357 361
36. R.N. Re The origins of intracrine hormone action Am. J. Med. Sci. 323 2002 43 48
37. R.N. Re The intracrine hypothesis and intracellular peptide hormone action Bioessays 25 2003 401 409
38. B.P. Roques, and F. Noble Dual inhibitors of enkephalin-degrading enzymes (neutral endopeptidase 24.11 and aminopeptidase N) as potential medications in the management of pain and opioid addiction NIDA Res. Monogr. 147 1995 104 145
39. B.P. Roques, F. Noble, and M.C. Fournie-Zaluski Endogenous opioid peptides and analgesia C. Stein Opioids in Pain Control. Basic and Clinical Aspects 1999 Cambridge University Press 21 45
40. A. Safavi, and L.B. Hersh Degradation of dynorphin-related peptides by the puromycin sensitive aminopeptidase and aminopeptidase M J. Neurochem. 65 1995 389 395
41. J. Shani, R. Azov, and B.A. Weissman Enkephalin levels in rat brain after various regimens of morphine administration Neurosci. Lett. 12 1979 319 322
42. C.N. Shrimpton, A.I. Smith, and R.A. Lew Soluble metallopeptidases and neuroendocrine signaling Endocrine Rev. 23 2002 647 664
43. R. Simantov, and S.H. Snyder Elevated levels of enkephalin in morphine-dependent rats Nature 262 1976 505 507
44. K.A. Trujillo, and H. Akil Opiate tolerance and dependence: recent findings and synthesis The New Biologist 10 1991 915 923
45. K.A. Trujillo, D.M. Bronstein, I.O. Sanchez, and H. Akil Effects of chronic opiate and opioid antagonist treatment on striatal opioid peptides Brain Res. 698 1995 69 78
46. A.J. Turner Endopeptidase-24.11 and neuropeptide metabolism A.J. Turner Neuropeptides and their peptidases 1987 Ellis Horwood Ltd. Chichester 183 201
47. T.L. Wang, and H. Chang Intravenous morphine reduces plasma endothelin 1 concentration through activation of neutral endopeptidase 24.11 in patients with myocardial infarction Ann. Emerg. Med. 37 2001 445 449
48. B.A. Weissman, and N. Zamir Differential effects of heroin on opioid levels in the rat brain Eur. J. Pharmacol. 139 1987 121 123
49. H.L. Wen, W.K. Ho, and P.Y. Wen Comparison of the effectiveness of different opioid peptides in suppressing heroin withdrawal Eur. J. Pharmacol. 100 1984 155 162
50. S. Wilk, E. Wilk, and R.P. Magnusson Purification, characterization and cloning of a cytosolic aspartyl aminopeptidase J. Biol. Chem. 273 1998 15961 15970
51. I.S. Zagon, and P.J. McLaughlin Endogenous opioid systems regulate cell proliferation in the developing rat brain Brain Res. 412 1987 68 72
52. I.S. Zagon, M.F. Verderame, and P.J. McLaughlin The biology of the opioid growth factor receptor (OGFr) Brain Res. Rev. 38 2002 351 376